|
End-of-day quote
Thailand S.E.
22/10/2026
|
5-day change | 1st Jan Change | ||
| 3.720 THB | +1.64% |
|
+2.76% | - |
| 10-25 | Roche Targets Emerging Oncology Market With New Lung-Cancer Drug | DJ |
| 10-25 | AstraZeneca's Imfinzi Combo Therapy Reduces Death Risk in Late-stage Small Cell Lung Cancer Trial | MT |
| Market Cap | 237B 8,019B 212B 196B 178B 332B 22,544B 338B 2,358B 933B 11,811B 891B 872B 37,238B | P/E 2026 * |
27.9x | P/E 2027 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 279B 9,416B 249B 230B 208B 390B 26,470B 396B 2,768B 1,096B 13,868B 1,046B 1,024B 43,723B | EV / Sales 2026 * |
7.16x | EV / Sales 2027 * | 6.76x |
| Free-Float |
99.77% | Yield 2026 * |
2.3% | Yield 2027 * | 2.43% |
Last Transcript: Amgen Inc.
| 1 day | +1.64% | ||
| 1 week | +2.76% | ||
| Current month | +5.08% | ||
| 1 month | +8.77% | ||
| 3 months | +18.47% | ||
| 6 months | +30.07% |
| 1 week | 3.58 |  | 3.74 |
| 1 month | 3.34 | | 3.74 |
| Current year | 2.6 | | 3.74 |
| 1 year | 2.6 | | 3.74 |
| 3 years | 2.6 | | 3.74 |
| 5 years | 2.6 | | 3.74 |
| 10 years | 2.6 | | 3.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 30/04/2012 |
| Director of Finance/CFO | 62 | 12/05/2010 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 31/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 31/12/2012 |
Tyler Jacks
BRD | Director/Board Member | 65 | 31/12/2011 |
Robert Eckert
BRD | Director/Board Member | 71 | 31/12/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.64% | +2.76% | - | - | 237B | |
| -2.54% | +1.31% | +54.27% | +117.14% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.05% | 635B | |
| +0.16% | +0.08% | +25.29% | +96.64% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.55% | 378B | |
| -1.34% | -0.47% | +66.04% | +40.18% | 358B | |
| -0.68% | +2.65% | +22.98% | +49.15% | 295B | |
| -1.20% | +3.04% | +2.33% | +21.60% | 266B | |
| -1.79% | +1.57% | +50.56% | +61.40% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.06% | 193B | |
| Average | -0.82% | +1.60% | +37.02% | +69.31% | 444.85B | |
| Weighted average by Cap. | -1.18% | +1.63% | +41.02% | +80.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.97B 1,316B 34.8B 32.15B 29.13B 54.51B 3,699B 55.41B 387B 153B 1,938B 146B 143B 6,111B | 40.38B 1,363B 36.06B 33.31B 30.19B 56.47B 3,833B 57.41B 401B 159B 2,008B 152B 148B 6,331B |
| Net income | 8.56B 289B 7.64B 7.06B 6.4B 11.97B 812B 12.16B 84.93B 33.63B 426B 32.11B 31.43B 1,342B | 9.43B 318B 8.42B 7.78B 7.05B 13.19B 895B 13.41B 93.61B 37.06B 469B 35.39B 34.64B 1,479B |
| Net Debt | 41.36B 1,397B 36.93B 34.12B 30.92B 57.84B 3,926B 58.8B 411B 163B 2,057B 155B 152B 6,485B | 35.3B 1,192B 31.53B 29.12B 26.39B 49.38B 3,351B 50.19B 350B 139B 1,756B 132B 130B 5,536B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/10/26 | THB 3.720 | +1.64% | 22,515 |
| 21/10/26 | THB 3.660 | +1.10% | 37,766 |
| 20/10/26 | THB 3.620 | -0.55% | 122,274 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
- AMGN06 Stock
Select your edition
All financial news and data tailored to specific country editions
